Page last updated: 2024-08-26

artesunic acid and Cancer of Head

artesunic acid has been researched along with Cancer of Head in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fujimoto, Y; Inukai, D; Ogawa, T; Okamoto, H; Sano, R; Shimada, A; Suzuki, S; Ueda, H; Ueda, R; Yamanaka, S; Yoshikawa, K1
Jang, H; Kim, EH; Roh, JL; Shin, D1

Other Studies

2 other study(ies) available for artesunic acid and Cancer of Head

ArticleYear
Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels.
    Oncology reports, 2023, Volume: 50, Issue:2

    Topics: Aged; Apoptosis; Artemisinins; Artesunate; Cell Cycle; Cell Proliferation; Cisplatin; Head and Neck Neoplasms; Humans; Iron; Squamous Cell Carcinoma of Head and Neck

2023
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Redox biology, 2017, Volume: 11

    Topics: Alkaloids; Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Chromans; Cisplatin; Cyclohexylamines; Drug Repositioning; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Heme Oxygenase-1; Humans; Iron; Kelch-Like ECH-Associated Protein 1; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; NF-E2-Related Factor 2; Phenylenediamines; Reactive Oxygen Species; Signal Transduction; Xenograft Model Antitumor Assays

2017